DARE - Daré Bioscience, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue----
Cost of Revenue625-400-
Gross Profit-625--400-
Operating Expenses
Research Development6,413.956984.74972.66672.666
Selling General and Administrative4,655.8371,744.853157.92594.539
Non Recurring----
Others----
Total Operating Expenses11,694.7932,729.602630.59194.539
Operating Income or Loss-11,694.793-2,729.602-630.591-94.539
Income from Continuing Operations
Total Other Income/Expenses Net-5,044.022-8,773.515-42.096-
Earnings Before Interest and Taxes-11,694.793-2,729.602-630.591-94.539
Interest Expense--316.805-42.096-42.096
Income Before Tax-16,738.815-11,503.117-672.687-94.539
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-16,738.815-11,503.117-672.687-94.539
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-16,738.815-11,503.117-672.687-94.539
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-16,738.815-11,503.117-672.687-94.539